Literature DB >> 10987697

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

J G Bartlett1, S F Dowell, L A Mandell, T M File, D M Musher, M J Fine.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10987697      PMCID： PMC7109923          DOI： 10.1086/313954

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  201 in total

1.  The value of routine microbial investigation in community-acquired pneumonia.

Authors:  L Trevisani; S Putinati; S Sartori; L Ballerin; A Potena
Journal:  Respir Med       Date:  1992-03       Impact factor: 3.415

2.  High-resolution computed tomography for the diagnosis of community-acquired pneumonia.

Authors:  H Syrjälä; M Broas; I Suramo; A Ojala; S Lähde
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

3.  Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?

Authors:  R Dagan; O Abramson; E Leibovitz; D Greenberg; R Lang; S Goshen; P Yagupsky; A Leiberman; D M Fliss
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

4.  Clinical prediction rule for pulmonary infiltrates.

Authors:  P S Heckerling; T G Tape; R S Wigton; K K Hissong; J B Leikin; J P Ornato; J L Cameron; E M Racht
Journal:  Ann Intern Med       Date:  1990-11-01       Impact factor: 25.391

5.  Doxycycline activity against Streptococcus pneumoniae.

Authors:  K W Shea; B A Cunha; Y Ueno; F Abumustafa; S M Qadri
Journal:  Chest       Date:  1995-12       Impact factor: 9.410

Review 6.  Community-acquired pneumonia: the future of the microbiology laboratory: focused diagnosis or syndromic management?

Authors:  K S MacDonald; S R Scriver; M Skulnick; D E Low
Journal:  Semin Respir Infect       Date:  1994-09

7.  Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service.

Authors: 
Journal:  Q J Med       Date:  1987-03

8.  Effectiveness of influenza vaccine in health care professionals: a randomized trial.

Authors:  J A Wilde; J A McMillan; J Serwint; J Butta; M A O'Riordan; M C Steinhoff
Journal:  JAMA       Date:  1999-03-10       Impact factor: 56.272

9.  Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnesses.

Authors:  R L Moolenaar; C Dalton; H B Lipman; E T Umland; M Gallaher; J S Duchin; L Chapman; S R Zaki; T G Ksiazek; P E Rollin
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

10.  PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES.

Authors:  C M Macleod; R G Hodges; M Heidelberger; W G Bernhard
Journal:  J Exp Med       Date:  1945-11-30       Impact factor: 14.307
View more
  275 in total

1.  Ongoing issues in pneumonia care: when to admit, how to treat and the role of oral therapy.

Authors:  A C Shillington
Journal:  J Med Syst       Date:  2000-10       Impact factor: 4.460

2.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

3.  Managing community-acquired pneumonia.

Authors:  J G Bartlett
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  Email recruitment to use web decision support tools for pneumonia.

Authors:  James R Flanagan; Michael Peterson; Charles Dayton; Lori Strommer Pace; Andrew Plank; Kristy Walker; William S Carlson
Journal:  Proc AMIA Symp       Date:  2002

5.  Ambulatory community-acquired pneumonia: the predominance of atypical pathogens.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10       Impact factor: 3.267

6.  Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent North American isolates of Streptococcus pneumoniae.

Authors:  Sue E Baum; Sharon A Crawford; M L McElmeel; Cynthia G Whitney; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

7.  How do we optimize outcomes for patients with severe community-acquired pneumonia?

Authors:  Michael S Niederman
Journal:  Intensive Care Med       Date:  2002-08       Impact factor: 17.440

8.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.

Authors:  W S Lim; M M van der Eerden; R Laing; W G Boersma; N Karalus; G I Town; S A Lewis; J T Macfarlane
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

9. 

Authors:  J E Losa García; M R Martín de Cabo
Journal:  Medicine (Madr)       Date:  2013-04-03

Review 10.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.